GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
4GDI | H6QM85 | A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/164/2009 | |
4GDJ | H6QM95 | A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/060/2010 | |
8EFJ | P47811 | A structural study of selectivity mechanisms for JNK3 and p38 alpha with indazole scaffold probing compounds | |
7ALL | Q89YP8 | A single sulfatase is required for metabolism of colonic mucin O-glycans and intestinal colonization by a symbiotic human gut bacterium (BT4683-S1_4) | |
7AN1 | Q8A789 | A single sulfatase is required for metabolism of colonic mucin O-glycans and intestinal colonization by a symbiotic human gut bacterium (BT1636-S1_20) | |
7OQD | Q8A789 | A single sulfatase is required for metabolism of colonic mucin O-glycans and intestinal colonization by a symbiotic human gut bacterium (BT1636-S1_20) | |
7ANA | Q8A7A3 | A single sulfatase is required for metabolism of colonic mucin O-glycans and intestinal colonization by a symbiotic human gut bacterium (BT1622-S1_20) | |
2LMS | P01563 | A single GalNAc residue on Threonine-106 modifies the dynamics and the structure of Interferon alpha-2a around the glycosylation site | |
6Q40 | F9XHX3 | A secreted LysM effector of the wheat pathogen Zymoseptoria tritici protects the fungal hyphae against chitinase hydrolysis through ligand-dependent polymerisation of LysM homodimers | |
8INP | 8INP | A reversible glycosyltransferase of tectorigenin - Bc7OUGT | |
5BUO | P05067 | A receptor molecule | |
5LU5 | A0A095TT41 | A quantum half-site enzyme | |
5D4Y | 5D4Y | A psychrophilic glycoside hydrolase family 10 endo-beta-1,4-xylanase | |
2DWP | Q16875 | A pseudo substrate complex of 6-phosphofructo-2-kinase of PFKFB | |
6TYS | Q9IH63 | A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection | |
6TYS | 6TYS | A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection | |
6TYS | Q9IH63 | A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection | |
6TYS | 6TYS | A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection | |
8K45 | P0DTC2 | A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicron strains | |
8K45 | 8K45 | A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicron strains | |
8K46 | P0DTC2 | A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicron strains | |
8K46 | 8K46 | A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicron strains | |
8K47 | P0DTC2 | A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicron strains | |
8K47 | 8K47 | A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicron strains | |
7U2N | O93430 | A novel compound mimics the structural and functional effects of the full agonist glycine on glycine channels-open state | |
7U2M | O93430 | A novel compound mimics the structural and functional effects of the full agonist glycine on glycine channels-desenstized state | |
7U2O | O93430 | A novel compound mimics the structural and functional effects of the full agonist glycine on glycine channels-Expanded-open state | |
1U8C | P06756 | A novel adaptation of the integrin PSI domain revealed from its crystal structure | |
1U8C | P05106 | A novel adaptation of the integrin PSI domain revealed from its crystal structure | |
6B72 | P03407 | A novel HIV-1 Nef dimer interface induced by a single octyl-glucoside molecule | |
3OAY | 3OAY | A non-self sugar mimic of the HIV glycan shield shows enhanced antigenicity | |
3OAZ | 3OAZ | A non-self sugar mimic of the HIV glycan shield shows enhanced antigenicity | |
3OB0 | 3OB0 | A non-self sugar mimic of the HIV glycan shield shows enhanced antigenicity | |
4KWN | D9J2T9 | A new stabilizing water structure at the substrate binding site in ribosome inactivating protein from Momordica balsamina at 1.80 A resolution | |
1Y75 | Q5G291 | A new form of catalytically inactive phospholipase A2 with an unusual disulphide bridge Cys 32- Cys 49 reveals recognition for N-acetylglucosmine | |
1Y75 | Q5G290 | A new form of catalytically inactive phospholipase A2 with an unusual disulphide bridge Cys 32- Cys 49 reveals recognition for N-acetylglucosmine | |
3U7B | 3U7B | A new crystal structure of a Fusarium oxysporum GH10 xylanase reveals the presence of an extended loop on top of the catalytic cleft | |
3WHE | 3WHE | A new conserved neutralizing epitope at the globular head of hemagglutinin in H3N2 influenza viruses | |
3WHE | T2HNI1 | A new conserved neutralizing epitope at the globular head of hemagglutinin in H3N2 influenza viruses | |
4UQG | E1C9K5 | A new bio-isosteric base pair based on reversible bonding | |
6W35 | K7CID1 | A new Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry | |
8XKI | P0DTC2 | A neutralizing nanobody VHH60 against wt SARS-CoV-2 | |
8XKI | 8XKI | A neutralizing nanobody VHH60 against wt SARS-CoV-2 | |
7D6I | P0DTC2 | A neutralizing MAb targeting receptor-binding-domain of SARS-CoV-2 | |
7D6I | 7D6I | A neutralizing MAb targeting receptor-binding-domain of SARS-CoV-2 | |
1JJB | P04058 | A neutral molecule in cation-binding site: Specific binding of PEG-SH to Acetylcholinesterase from Torpedo californica | |
7FGB | 7FGB | A naturally-occurring neuraminidase-inhibitors-resistant NA from asiatic toad influenza B-like virus | |
7FGC | 7FGC | A naturally-occurring neuraminidase-inhibitors-resistant NA from asiatic toad influenza B-like virus | |
4ZB2 | P24300 | A native form of glucose isomerase collected at room temperature. | |
5MTF | B7MDQ0 | A modular route to novel potent and selective inhibitors of rhomboid intramembrane proteases |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024